Home > Inhibitors & Agonists

Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3551 Nalbuphine Hydrochloride Mixed agonist/antagonist opioid modulator, binding with high affinity to the MOR and KOR, and having relatively low affinity for the DOR
DCC3552 Naph-o2 Novel fluorescent probe for detection of endogenously produced Naph-O2˙– in living cells and tissues
DCC3553 Naphthyridine-azaquinolone Novel repeat-structure-specific DNA ligand, specifically binding slipped-CAG DNA intermediates of expansion mutations
DCC3554 Naphyrone Hydrochloride Triple reuptake inhibitor
DCC3555 Napi2b Inhibitor 15 Novel Gut-Restricted Inhibitor of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia
DCC3556 Napitane Mesylate Antagonist of alpha-2 adrenergic receptors and inhibitor of the neuronal uptake of norepinephrine
DCC3557 Napsagatran Inhibitor of extrinsic and intrinsic thrombin generation, inhibiting clot-bound and free (fluid-phase thrombin)
DCC3558 N-arachidonoyl Taurine Activator of the transient receptor potential vanilloid (TRPV) channels TRPV1 and TRPV4
DCC3559 Nargenicin Natural DnaE1 blocker, inducing a DNA damage response in Mycobacterium tuberculosis (Mtb) and inhibiting growth by blocking the replicative DNA polymerase, DnaE1
DCC3560 Tylophorine Potent suppressor of inducible nitric oxide synthase (iNOS; NOS II)
DCC3561 Nav1.1-in-b Novel selective NaV1.1 inhibitor, reducing visceral hypersensitivity
DCC3562 Nav1.7 Blocker-13 Novel selective blocker of NaV1.7 with little affinity for NaV 1.2, 1.3, or 1.6, being more potent at human vs guinea pig NaV1.7
DCC3563 Nav1.7 Blocker-24 Potent and selective blocker of voltage-gated Nav1.7 sodium channels
DCC3564 Nav1.7 Blocker-801 Potent NaV1.7 blocker, being 5-10 fold more potent than NaV 1.2 and NaV 1.6
DCC3565 Navarixin Novel CXC chemokine receptor 2 (CXCR2) antagonist
DCC3566 Naveglitazar Dual peroxisome proliferator-activated receptor gamma and alpha (PPARgamma and PPARalpha) agonist
DCC3567 Naxifylline Potent and selective A1 adenosine receptor antagonist
DCC3568 Nb-360 Biological Active Reagents
DCC3569 Nb-caged Tyrosine Hydrochloride L-Tyrosine caged with photosensitive ortho-nitrobenzyl side chain
DCC3570 Nbd-09027 Novel HIV-1 entry inhibitor
DCC3571 Nbd-10007 Novel HIV-1 entry inhibitor
DCC3572 Nbd-14136 Novel CD4-mimetic HIV-1 entry inhibitor
DCC3573 N-bn-thaz Fumarate Potent agonist of the human 5-HT2A and 5-HT2C receptors
DCC3574 Nboh-2c-cn Hydrochloride Potent and selective 5-HT2A receptor agonist
DCC3575 Nbti-5463 Novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy
DCC3576 nc00094221 M. tuberculosis Dihydrofolate Reductase Inhibitor
DCC3577 Nc2213 Novel inhibitor of methionine aminopeptidase 2 (MetAP2)
DCC3578 Ncats-sm1440 First-in-class, potent, and selective Lactate dehydrogenase inhibitor
DCC3579 Ncats-sm1441 First-in-class, potent, and selective Lactate dehydrogenase inhibitor
DCC3580 Ncb0970 Less active trans-isomer of NCB-0846, acting as the negative control for NCB-0846, showing 13-fold weaker TNIK enzyme-inhibitory activity

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X